Clinical Factors Affecting Daily Dosage of Desmopressin Orally Disintegrating Tablets in Arginine Vasopressin Deficiency.

Yoshitomo Hoshino Kosuke InoueSara IkedaYukiko GoshimaKeita TatsushimaNoriaki FukuharaMitsuo OkadaHiroshi NishiokaShozo YamadaYasuhiro TakeuchiAkira Takeshita

Published in: The Journal of clinical endocrinology and metabolism (2023)

To achieve the safe and stable treatment of AVP-D, the daily dose of ODT needs to be selected based on a patient's sex, age, and eCCr under appropriate sublingual administration by patient education.

Keyphrases

case report
physical activity
healthcare
nitric oxide
quality improvement